Intra-Cellular Therapies Inc (NASDAQ:ITCI)
| 30.11 Delayed Data As of Apr 19 |  -1.09 / -3.49%Today’s Change | 16.14 Today|||52-Week Range 40.01 | -5.31% Year-to-Date |
Latest ITCI News | Press Releases
No recent news for Intra-Cellular Therapies Inc.
Today’s Trading
| Previous close | 31.22 |
| Today’s open | 31.22 |
| Day’s range | 29.59 - 31.50 |
| Volume | 414,017 |
| Average volume (3 months) | 632,454 |
| Market cap | $2.5B |
Data as of 3:59pm ET, 04/19/2021
Growth & Valuation
| Earnings growth (last year) | -20.52% |
| Earnings growth (this year) | +2.48% |
| Earnings growth (next 5 years) | +2.50% |
| Revenue growth (last year) | +37,537.11% |
| P/E ratio | NM |
| Price/Sales | 98.08 |
| Price/Book | 3.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LGNDLigand Pharmaceutica... | -4.23 | -2.82% |
| ---- | ||
| VCELVericel Corp | -3.85 | -6.57% |
| GBTGlobal Blood Therape... | -0.01 | -0.02% |
Data as of 4:00pm ET, 04/19/2021
Financials
| Next reporting date | May 12, 2021 |
| EPS forecast (this quarter) | -$0.79 |
| Annual revenue (last year) | $22.8M |
| Annual profit (last year) | -$227.0M |
| Net profit margin | -995.07% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
